LTF and Parkinson disease: Fecal calprotectin, lactoferrin, and the E. coli/Lactobacillus ratio ranked highest in feature importance, suggesting that gut microbiota characteristics and related inflammatory markers may serve as core biomarkers for predicting PD treatment efficacy.